Exhibit 99.2

BRIACELL THERAPEUTICS CORP.

REPORT OF VOTING RESULTS

In accordance with section 11.3 of National Instrument 51-102 – Continuous Disclosure Obligations, this report briefly describes the matters voted upon and the outcome of the votes at the annual general and special meeting of shareholders of BriaCell Therapeutics Corp. (the “Company”) held virtually via teleconference on January 18, 2022 (the “Meeting”). Each of the matters is described in greater detail in the Company’s management information circular dated December 20, 2021 (the “Circular”).

1. Election of Directors.

Each of the nominees set for in the Circular were elected as directors to serve until the next annual meeting of shareholders, or until their respective successors are elected or appointed. The following table sets forth the vote of the shareholders at the Meeting with respect to the election of directors:

	For					Withheld
Nominee	Actual		Percentage			Actual		Percentage
Dr. William V. Williams		2,286,353		97.68	%		54,346		2.32	%
Mr. Jamieson Bondarenko		2,286,214		97.67	%		54,485		2.33	%
Mr. Marc Lustig		2,285,435		97.64	%		55,263		2.36	%
Dr. Rebecca Taub		2,327,126		99.42	%		13,573		0.58	%
Mr. Vaughn C. Embro-Pantalony		2,285,426		97.64	%		55,273		2.36	%
Mr. Martin Schmieg		2,326,345		99.39	%		14,353		0.61	%
Dr. Jane Gross		2,327,674		99.44	%		13,024		0.56	%

2. Appointment of MNP LLP.

The Company’s shareholders approved the appointment of MNP LLP as auditors of the Company to hold office until the close of the next annual meeting of shareholders of the Company at such remuneration as may be fixed by the directors of the Company. The following table sets forth the vote of the shareholders at the Meeting with respect to the appointment of MNP LLP:

For					Withheld
Actual		Percentage			Actual		Percentage
	2,322,712		99.23	%		17,986		0.77	%

3. Renewal of the Stock Option Plan

The Company’s shareholders approved the renewal of the Company’s Stock Option Plan adopted on November 25, 2014 (the “Stock Option Plan”). The following table sets forth the vote of the shareholders at the Meeting with respect to the approval of the renewal of the Stock Option Plan:

For					Against
Actual		Percentage			Actual		Percentage
	2,256,743		96.41	%		83,955		3.59	%

4. Adoption of Amendment to the Authorized Share Structure and Articles of the Company

The Company’s shareholders approved an amendment to the authorized share structure and articles of the Company to create a new class of shares (the “New Shares”) and to vary the rights and restrictions attached to the common shares to reflect the creation of the New Shares. The following table sets forth the vote of the shareholders at the Meeting with respect to the approval of the amendment to the authorized share structure and articles of the Company:

For					Against
Actual		Percentage			Actual		Percentage
	2,215,298		94.64	%		125,401		5.36	%

Date: January 18, 2022